granted
on 31 Jan 2024
Last Applicant/ Owned by
No. 581-1, Ruiguang Rd., Neihu Dist.
Taipei City
TW
11492
Serial Number
90431302 filed on 30th Dec 2020
Registration Number
N/A
Correspondent Address
Zhi Dong
Filing Basis
1. intent to use
2. intent to use current
3. filed as use application
Disclaimer
NO DATA
Biological preparations for medical purposes, namely, gene modified immune cell therapies for the treatment of cancers, autoimmune diseases, inflammatory diseases, hypersensitivity, transplantation rejection, infectious diseases and neurodegenerative diseases; biological preparations for veterinary purposes for the treatment of cancers, autoimmune diseases, inflammatory diseases, hypersensitivity,Read More
Biological preparations for medical purposes, namely, gene modified immune cell therapies for the treatment of cancers, autoimmune diseases, inflammatory diseases, hypersensitivity, transplantation rejection, infectious diseases and neurodegenerative diseases; biological preparations for veterinary purposes for the treatment of cancers, autoimmune diseases, inflammatory diseases, hypersensitivity, transplantation rejection, infectious diseases and neurodegenerative diseases; biological tissue cultures for medical purposes, namely, human blood samples, human allograft tissues, human umbilical cord blood and human induced pluripotent stem cells (iPSCs) from somatic cells; biological tissue cultures for veterinary purposes, namely, animal blood samples, tumors and allograft tissues; blood for medical purposes; cultures of microorganisms for medical or veterinary use; diagnostic biomarker reagents for medical purposes, namely, chemical and biological reagents for medical or veterinary purposes; diagnostic preparations for medical purposes; diagnostic preparations for veterinary purposes; pharmaceuticals, namely, drugs for medical purposes, namely, for treating cancers, autoimmune diseases, inflammatory diseases, and neurodegenerative diseases; enzymes for medical purposes; enzymes for veterinary purposes; immunostimulants; medicinal infusions for treating cancers, autoimmune diseases, inflammatory diseases, and neurodegenerative diseases; pharmaceuticals, namely, medicines for human purposes, namely, for treating cancers, autoimmune diseases, inflammatory diseases, and neurodegenerative diseases; pharmaceuticals, namely, medicines for veterinary purposes, namely, for veterinary cancers; preparations of microorganisms for medical or veterinary use, namely, cultures of bacteria and viruses for medical or veterinary use; pharmaceutical preparations for treating cancers, autoimmune diseases, inflammatory diseases, and neurodegenerative diseases; pharmaceutical preparations, namely, gene modified immune cell therapies for the treatment of cancers, autoimmune diseases, inflammatory diseases, hypersensitivity, transplantation rejection, infectious diseases and neurodegenerative diseases; pharmaceuticals, namely, gene modified immune cell therapies for the treatment of cancers, autoimmune diseases, inflammatory diseases, hypersensitivity, transplantation rejection, infectious diseases and neurodegenerative diseases; pharmaceuticals in the nature of pharmaceutical preparations for treating cancers, autoimmune diseases, inflammatory diseases, and neurodegenerative diseases; transplants comprised of living cells, namely, genetically engineered tissues for medical and transplant purposes; genetically engineered cells for medical purposes, specifically for transplantation purposes; vaccines
No 90431302
No Service/Collective Mark
No 08688.1629US
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
02th Feb 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
31st Jan 2024 | SOU TEAS EXTENSION RECEIVED |
31st Jan 2024 | SOU EXTENSION 3 FILED |
31st Jan 2024 | SOU EXTENSION 3 GRANTED |
29th Jul 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
27th Jul 2023 | SOU TEAS EXTENSION RECEIVED |
27th Jul 2023 | SOU EXTENSION 2 FILED |
27th Jul 2023 | SOU EXTENSION 2 GRANTED |
22nd Nov 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
18th Nov 2022 | SOU TEAS EXTENSION RECEIVED |